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Blood samples from Peromyscus leucopus mice captured at an enzootic site in Connecticut were examined for
antibodies to and DNA of Borrelia burgdorferi, to characterize the dynamics of infection in this reservoir
population. From trappings conducted over the course of 2 transmission seasons, 598 (75%) of 801 serum
samples from 514 mice were found to be positive by enzyme immunoassay. Seropositivity correlated with date
of capture and mouse age, was similar among locations within the site, increased from 57% to 93% over the
course of the transmission season, and was associated with antibodies to outer surface protein (Osp) C, but
not to OspA. Longitudinal samples from 184 mice revealed an incidence of 0.2 cases/mouse/week. Nineteen
(10%) of 187 samples were found by polymerase chain reaction to be positive for B. burgdorferi, and, of those,
14 (74%) were found to be seropositive. Nearly the entire population of P. leucopus mice became infected
with B. burgdorferi by late August, coinciding with the peak activity period of host-seeking larvae uninfected
with the spirochete Ixodes scapularis, thereby perpetuating the agent through succeeding generations of ticks.
Vectorborne zoonotic infections are important causes
of morbidity and mortality in humans and agricultural
animals throughout the world. For the most part, un-
derstanding the pathogenesis and dynamics of immune
responses during these infections comes from studies
of model laboratory animals. Less is known about in-
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fections in the natural populations of vertebrates that
serve as reservoirs of pathogens. Since the risk of in-
fection for humans is correlated with the prevalence of
infection in reservoirs and vectors [1], disease control
programs, such as those targeting interventions to res-
ervoirs, would likely benefit from a better understand-
ing of the transmission dynamics of these infectious
agents among their hosts in their natural setting. With
this goal in mind, we began a field-based study, in a
reservoir host population, of infection with Borrelia
burgdorferi, which is an agent of Lyme borreliosis (LB),
the most common vectorborne zoonosis in the United
States and in much of Europe [2, 3].
In the Midwestern and northeastern United States,
the white-footed mouse, Peromyscus leucopus, is a major
reservoir host for B. burgdorferi [4–6]. The role of this
rodent as a source of B. burgdorferi infection for im-
mature Ixodes scapularis ticks has been documented [7,
8]. Limited serologic surveys of natural P. leucopus pop-
ulations have reported that, in areas in the northeastern
United States where LB is highly endemic, 30%–80%
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of captured mice have antibodies to B. burgdorferi, and sero-
prevalence peaks during summer months [9–11]. Seasonal var-
iation of infection of P. leucopus mice with B. burgdorferi has
been demonstrated by cultivation of the pathogen from the
mice [6, 12]. To date, there have been few studies of antibody
responses to and infection with B. burgdorferi in a natural pop-
ulation of P. leucopus mice during the spirochete’s transmission
season [6, 13]. Experimental infection of P. leucopus mice with
B. burgdorferi has demonstrated that immunity in the mice is
strain specific [14], but the relationship between infection and
immune responses among reservoir mice in nature has not been
well characterized.
Moreover, the characteristics of the antibody response of a
natural population of any B. burgdorferi reservoir are incom-
pletely understood. There have been few studies to determine
which B. burgdorferi antigens are immunologically recognized
by P. leucopus (or any other reservoir species) in the field. The
results of those studies that have examined this aspect are con-
flicting. For example, in one study [15] but not in others [6,
13], the presence of what appear to be antibodies to outer
surface protein (Osp) A in the serum samples from field P.
leucopus mice has been reported to be common. This is not a
trivial point. If P. leucopus mice commonly do have antibodies
to OspA, these may affect the transmission of B. burgdorferi to
the host mouse by killing the spirochetes in the midgut of the
engorging tick [16]. On the other hand, if P. leucopus mice
commonly do not have antibodies to OspA, then this reservoir
species could be an appropriate target for a field-administered
vaccine designed to prevent the transmission of B. burgdorferi
between vectors and reservoirs [17].
For the present study, we used both serologic assays and a
polymerase chain reaction (PCR) assay to characterize B. burg-
dorferi infection in P. leucopus mice both captured and released
at a field site in Connecticut during the summer months of 2
consecutive years. By the end of the transmission season by I.
scapularis nymphs, almost all the field mice from which samples
had been obtained were found to be seropositive for the spi-
rochete, and B. burgdorferi DNA was detectable in ∼10% of
blood samples, even in those from mice with antibodies to B.
burgdorferi. OspC was the most commonly recognized antigen,
but the occurrence of antibodies to OspA was rare.
MATERIALS AND METHODS
Field study. Mice were trapped on nine 1.2-hectare plots, in
a mixed hardwood forest, on property owned by a private water
company near New Haven, Connecticut. The plots were dis-
tributed among 3 sites (1, 2, and 3) that were separated by
100–1500 m. Each plot consisted of a array of live traps93 9
that were baited with peanut butter for 2–4 consecutive nights/
trapping period. We rotated sequentially among the 3 sites, with
∼21 days between visits to the same plot, resulting in 4 trapping
periods/plot and a total of 12 trapping periods during late May
to August, for both 1998 and 1999. Captured mice were marked
with uniquely numbered ear tags. Mice were classified as ju-
veniles (if they were !15 g and if their pelage [fur] was entirely
gray), as subadults (if they were 15–17 g and/or if their pelage
was a mix of gray and brown), and as adults (if they were 117
g and if their pelage was entirely brown) [18]. Blood samples
were obtained from the retro-orbital sinus while mice were
under ketamine anesthesia; after recovery, mice were released
at the point of capture. For mice recaptured within a trapping
period, samples were not obtained a second time. The verte-
brate animal protocol #07596 was approved for the present
study by Yale University.
In 1998, but not in 1999, mice were subjected to a pilot study
of field immunizations by injection with either recombinant
OspA of B. burgdorferi or a negative control immunogen, glu-
tathione S-transferase [19]. The mice captured at the negative
control plots formed the basis for the longitudinal analyses. To
increase the analytical power of the prevalence-over-time sur-
vey, we also used serum samples from first-time-captured mice,
samples obtained before vaccination with OspA.
Laboratory infections and immunizations. Twenty adult,
female, laboratory-reared P. leucopus mice (Genetic Stock Cen-
ter, University of South Carolina, Columbia) were infected with
the Valhalla strain of B. burgdorferi via feeding by laboratory-
reared, infected nymphs of I. scapularis, as described elsewhere
[20]. Infection of mice was confirmed by use of xenodiagnostic
larval I. scapularis [7]. Blood was obtained from the mice before
infestation with the ticks and again 4 weeks later. Two additional
mice were infected by intradermal injection of 104 cells of the
Sh-2–82 strain of B. burgdorferi [21]. Blood samples were ob-
tained 60 weeks later from these mice and from 6 uninfected
P. leucopus mice of the same age. For immunizations, 5 P.
leucopus mice were injected intramuscularly with 1 mg of pu-
rified, lipidated recombinant OspA (rOspA) that was derived
from B. burgdorferi strain B31 [22, 23] and diluted in normal
saline, and 5 mice received saline alone. Mice were injected on
days 0 and 14, and blood samples were obtained on day 42.
EIA and immunoblot analysis. For all assays, serum sam-
ples were diluted 1:100 in PBS. For whole-cell EIA of serum
samples obtained from field mice in 1998 and of serum samples
obtained from laboratory-infected mice, a commercial kit
(MarDx) based on strain B31 of B. burgdorferi was used (B31
EIA). For whole-cell EIA of serum samples obtained in 1999,
strain B314, a B31 derivative that expresses OspC in great abun-
dance but does not express OspA or OspB, was used (B314
EIA) [24]. The procedure for this and for the EIA using purified
rOspA has been described elsewhere [25]. Goat anti–P. leucopus
IgG heavy and light chains conjugated to alkaline phosphatase
(Kirkegaard Perry Laboratories) were used as secondary anti-
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Figure 1. Immunoblot analysis of antibodies to Borrelia burgdorferi
antigens in serum samples from laboratory-infected, field-infected, and
uninfected (control) Peromyscus leucopus mice. The serum samples were
incubated with commercial strips. The binding of antibodies was detected
by use of alkaline phosphatase–conjugated goat anti–P. leucopus im-
munoglobulin antiserum. Serum from a human patient with Lyme bor-
reliosis (LB) was the positive control. The location of selected B. burg-
dorferi antigens (83/93/100-kDa protein, P66, FlaB, BmpA, outer surface
protein [Osp] A, and OspC) were identified by use of monoclonal antibodies
and are shown on the left.
body. The cutoff value for a positive value by EIA was 3 SD
above the mean optical density value of serum samples from
noninfected, laboratory-reared P. leucopus mice.
Immunoblot assays using rOspA or the lysate of strain B312,
which produces both OspA and OspC abundantly [24], were
performed as described elsewhere [25]. Different proteins were
identified by use of monoclonal antibodies to OspA [26], FlaB
[27], P66 [28], BmpA (P39) [29], the 80/93/100-kDa protein
[30], and OspC (provided by Denee Thomas, University of
Texas Health Science Center, San Antonio). The 18-kDa protein
was identified by use of commercial blot strips based on strain
B31 (MarDx).
DNA extraction and PCR. Total DNA was extracted from
100-mL blood clots of field mice by use of the FastDNA kit (BIO
101 Systems) under a biological hood in an isolated room. A
684-bp fragment of the chromosomal p66 gene of B. burgdorferi
[31] was amplified by use of nested PCR using the following
primers (Genbank number X87725 coordinates): external for-
ward, 50-GATTTTTCTATATTTGGACACAT-30 (positions 985–
1007); external reverse, 50-TGTAAATCTTATTAGTTTTTCA-
AG-30 (positions 1717–1740); internal forward, 50-CAAAAAA-
GAAACACCCTCAGATCC-30 (positions 1026–1049); and in-
ternal reverse, 50-CCTGTTTTTAAATAAATTTTTGTAGCATC-
30 (positions 1681–1709). PCR conditions were the following:
947C for 3 min followed by 40 cycles of 947C for 1 min; 507C
for 2 min; and 747C for 2 min. Negative controls were included
throughout the DNA extraction and PCR preparation steps, for
each run of the assay. Amplicons were directly sequenced in both
directions, by use of the internal primers, on a CEQ8000 capillary
DNA sequencer (Beckman Coulter).
Statistical analyses. The means were determined for nu-
merical data and, unless indicated otherwise, are followed
throughout the text by 95% confidence intervals in parentheses.
Unpaired or paired t tests were used for comparing mean op-
tical density values for independent or dependent samples, re-
spectively. Multiple comparisons of means were analyzed by
analysis of variance (ANOVA) or covariance (ANCOVA). Pro-
portions were compared by use of x2 test or Fisher’s exact test.
Supplementary material. Some results are provided in
supplementary figures accompanying the online version of this
paper, at http://www.journals.uchicago.edu/JID/jounal/issues/
v189n8/31322/31322.html.
RESULTS
Laboratory infections and OspA immunization. To deter-
mine baseline antibody levels and cutoff values for EIAs using
serum samples from P. leucopus mice, immune responses to
whole-cell B. burgdorferi antigens were first evaluated in serum
samples from 26 uninfected and 20 experimentally infected P.
leucopus mice. By the whole-cell B31 EIA, the uninfected P.
leucopus mice had a mean OD value of 0.09 (0.08–0.10), with
a cutoff value of 0.15, and the infected P. leucopus mice had a
mean OD value of 0.27 (0.23–0.31) 4 weeks after infestation
with the ticks. For 6 uninfected, laboratory-reared P. leucopus
mice, by the whole-cell B314 EIA, the mean OD value was 0.10
(0.09–0.11), and the corresponding cutoff value was 0.25.
Although, in serum samples from uninfected P. leucopus
mice, antibodies to B. burgdorferi were not detectable by im-
munoblot, in the serum samples from laboratory-infected P.
leucopus mice, antibodies reacted with several B. burgdorferi
antigens, including the 83/93/100-kDa protein, P66, FlaB,
BmpA, and the 18-kDa protein (figure 1). Neither the serum
samples from laboratory-infected P. leucopus mice nor those
from the control mice had antibodies to OspA detectable by
either immunoblot or EIA with rOspA, but serum samples from
the 5 P. leucopus mice vaccinated with OspA had antibodies to
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Table 1. Summary of serum samples from Peromyscus leucopus
mice captured at a field site in Connecticut in 1998 and 1999 and
descriptive statistics of the results of whole-cell Borrelia burg-
dorferi EIAs.
Year
No. of
mice
No. of
serum
samples Antigena
EIA OD405
Mean (range)
Percentile
10th 90th
1998 267 355 B31 0.21 (0.05–0.57) 0.07 0.35
1999 247 446 B314 0.70 (0.06–2.02) 0.12 1.28
a B31, outer surface protein (Osp) A+OspC+ phenotype; B314, OspA2OspC+
phenotype.
Figure 2. Frequency distribution of whole-cell Borrelia burgdorferi EIA
OD405 values for serum samples obtained in 1998 (A) and 1999 (B) from
a natural population of Peromyscus leucopus mice.
OspA detectable by immunoblot and had reciprocal titers of
>320 detected by the EIA using rOspA, 6 weeks after the first
immunization.
Field studies. The mark-recapture data indicated that 79%
(72%–86%) and 78% (74%–82%) of the resident mouse pop-
ulations in 1998 and 1999, respectively, were captured [32].
Among mice captured at the 3 sites, 62% (50%–73%) in 1998
and 77% (65%–89%) in 1999 were recaptured by the last trap-
ping period. The mean (range) estimated abundance at negative
control plots was 17 (4–30) mice/ha in 1998 and 42 (23–62)
mice/ha in 1999 ( , ANOVA).P ! .001
Antibodies of field P. leucopus mice to whole cells of B.
burgdorferi. To assess the prevalence and yearly dynamics
of B. burgdorferi infection of P. leucopus mice captured at the
enzootic area, we analyzed a total of 801 serum samples ob-
tained from 514 mice during both years, by use of whole-cell
EIA. There was a greater range of values and a higher maximum
optical density by the B314 EIA in 1999 than by the B31 EIA
in 1998, but the minimum of the range and the 10th percentile
optical density values for low-reactivity samples were similar
for both assays, an indication of comparable specificities for
both assays (table 1). Within different treatment plots or sites
in 1998 and 1999, there were no significant differences in mean
optical density values for the samples ( , ANCOVA), andP 1 .1
the findings were pooled for each year.
Serum samples from the field mice showed a bimodal dis-
tribution of optical density values by whole-cell EIA, for each
of the years (figure 2). The first peaks (∼0.08 by the B31 EIA
[figure 2A] and ∼0.13 by the B314 EIA [figure 2B]) corre-
sponded to the range of values observed with uninfected P.
leucopus mice in the laboratory and suggests that field mice
with optical density values distributed around these first peaks
were uninfected. The distribution of samples around the second
peak (∼0.25 by the B31 EIA and ∼0.80 by the B314 EIA) cor-
responded to the range of values for serum samples from lab-
oratory-infected P. leucopus mice.
Figure 3 shows the mean values and percentages of sero-
positivity detectable by whole-cell EIA, by sampling intervals
over the course of the studies during 1998 and 1999. For com-
bined collection periods, the prevalence of seropositivity in-
creased from 83 (57%) of 146 samples at the start of the sam-
pling (late May to mid-June [days 146–164]) to 42 (93%) of
45 samples by the end of August (days 235–239) ( ;2x p 18.7
). There was a high coefficient of determination (r 2)P ! .001
between calendar day and mean values by EIA in both years,
and the regression curves for the plot of day against values by
EIA had similar slopes for 1998 and 1999. Extrapolating from
the regression curves, we estimated that the populations of P.
leucopus mice first had mean values by EIA above the cutoff
point by May 11 (day 130) in 1998 and by April 16 (day 106)
in 1999.
Antibodies of P. leucopus mice by age. We next deter-
mined the relationship between the estimated age of individual
mice and their respective antibody levels by use of whole-cell
EIA for serum samples obtained in 1999 ( ); also in-np 429
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Figure 3. Infection of Peromyscus leucopus mice with Borrelia burg-
dorferi over a transmission season, as determined by whole-cell B. burg-
dorferi EIA of serum samples and by p66 gene polymerase chain reaction
(PCR) assay of blood samples in 1998 (A) and 1999 (B). B31 cells were
used for EIA in 1998, and B314 cells were used in 1999. Sampling-day
intervals are indicated on the X-axis. EIA OD405 value intervals and the
percentage of positive serum samples for a sampling period are shown
on the left and the right Y-axis, respectively. Below the graph are the
total number of blood samples subjected to EIA and PCR analysis, from
different collection periods, as well as the number of samples that were
found to be positive by these assays. Coefficient of determination (r 2)
values between the collection dates and the values by EIA are shown.
cluded in this analysis were samples obtained from recaptured
mice. The average body mass and OD value, respectively, were
11.5 g (10.0–13.1 g) and 0.20 (0.11–0.29 ) for juveniles, 15.0
g (14.8–15.4 g) and 0.49 (0.40–0.58 ) for subadults, and 21.5
g (21.1–22.0 g) and 0.83 (0.77–0.90 ) for adults. Although the
juvenile and subadult groups did not differ significantly in op-
tical density values, both had significantly lower optical density
values than did the adult group ( , Bonferonni-correctedP ! .05
t test).
If younger mice have a lower prevalence of anti–B. burg-
dorferi antibodies than do older mice, then one would expect
that mice captured for the first time during a trapping period
would have lower antibody levels than mice that were recap-
tured on the same day. Accordingly, for both years, we matched
mice captured for the first time with recaptured mice, by use
of the date at which mice were sampled. The mean body mass
for mice captured for the first time and for recaptured mice
in 1998 was 15.9 g (14.8–16.9 g) and 17.8 g (16.9–18.7 g),
respectively, ( , paired t test), and that in 1999 was 17.5P ! .004
g (16.6–18.4 g) and 19.4 g (18.7–20.4 g), respectively (P !
). The mean OD values for 32 pairs of mice captured for.003
the first time and for recaptured mice in 1998 were 0.16 (0.12–
0.20) and 0.28 (0.24–0.32), respectively, ( , paired tP ! .0001
test). The corresponding OD values for 61 pairs of mice, in
1999, were 0.58 (0.47–0.68) and 0.89 (0.78–0.99), respectively,
( ).P ! .001
Antibodies to specific antigens of B. burgdorferi. A ran-
dom sample of 206 serum samples from mice captured in 1998
was analyzed by immunoblot, for antibodies to OspC, BmpA,
FlaB, P66, the 18-kDa and 80/93/100-kDa proteins, which are
included in a standard set of antigens for diagnostic testing
[33], and OspA. Figure 1 shows the patterns of reactivities of
4 representative serum samples from the mice. Of 206 serum
samples from P. leucopus mice captured at the field site, 138
(67%) had antibodies to OspC detectable by immunoblot. The
proportions with which other antigens were recognized were
the following: 37% for BmpA, 36% for the 18-kDa protein,
24% for the 83/93/100-kDa protein, 19% for P66, and 12% for
FlaB. Values by whole-cell B31 EIA were generally higher among
OspC-positive serum samples (mean OD, 0.26) than among
OspC-negative serum samples (mean OD, 0.13) ( , tP ! .0001
test). The mean OD value for 44 samples producing only 1 of
the 6 bands (0.21 [0.18–0.23]) was lower than that for 73
samples producing >3 of the 6 bands (0.28 [0.26–0.29]), by
immunoblot ( , t test). None of the 206 serum samplesP ! .001
had antibodies to OspA detectable by immunoblot.
Of 355 serum samples from 1998 that were examined by
EIA for antibodies to OspA, 353 (99.4%) had values less than
the cutoff value established for uninfected laboratory mice
(0.12). The only 2 serum samples (0.6%) that had optical den-
sity values above the cutoff value were confirmed by immu-
noblot to have antibodies to OspA.
Longitudinal studies of anti–B. burgdorferi antibodies in
P. leucopus mice. Table 2 summarizes the sampling fre-
quencies and median collection days for the longitudinal studies
of the total 184 mice captured at least twice during 1998 and
1999. In 1998, 34 (59%) of 58 mice were found to be sero-
positive at the first sampling, and, in 1999, 86 (68%) of 126
mice were found to be seropositive at th first sampling (P 1
). For both years, only 10 mice (5.4%) were found to be.2
seronegative at each sampling, and only 3 (1.6%) mice were
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Table 2. Summary of serum samples and results of whole-cell Borrelia burgdorferi EIA, for a longitudinal study of
Peromyscus leucopus mice captured at a field site in Connecticut.
Year
No. of
mice
No. of captures (median day of capture) Capture, mean EIA OD450 5 95% CI
1 2 3 4 1st 2nd 3rd 4th
1998 57 57 (175) 57 (195) 19 (223) 7a (232) 0.19 5 0.03 0.24 5 0.03 0.33 5 0.04 0.36 5 0.06
1999 126 126 (174) 126 (202) 65 (222) 8 (229) 0.58 5 0.07 0.83 5 0.07 0.90 5 0.08 0.80 5 0.29
NOTE. CI, confidence interval.
a One mouse was sampled 6 times in 1998.
Figure 4. Dynamics of seroconversion in field Peromyscus leucopus
mice. Cumulative plots for 20 and 34 mice that seroconverted in whole-
cell B. burgdorferi EIA in 1998 (black squares) and 1999 (black circles),
as well as an aggregate for both years (white squares), are shown.
Intervals, in weeks, between dates that paired serum samples were
obtained from mice that seroconverted are indicated on the X-axis. The
Y-axis shows the cumulative percentage of mice that seroconverted, by
sampling interval.
found to be seropositive at the first sampling and seronegative
subsequently. For both years, most mice either continued to
be seropositive (64%) or seroconverted (29%) during subse-
quent captures. Table 2 also shows the mean values by EIA, for
each capture for both years, which increased between the first
and second captures (1998 and 1999) and then again between
the second and third captures (1998) ( , Bonferroni-P ! .01
corrected ANOVA).
To estimate the incidence rate of B. burgdorferi infection
among the longitudinally sampled P. leucopus mice, we used
seroconversion from negative to positive, in the EIA, to define
a new case of infection. Figure 4 shows the cumulative sero-
positive prevalence over time for each year and for the com-
bined data. Infections accumulated in mice earlier in 1998 than
in 1999: 14 (70%) of 20 mice in 1998 and 4 (12%) of 34 mice
in 1999 ( ; ) seroconverted within the first 3-2x p 16.7 P ! .001
week sampling period.
For both years, the frequency of seroconversion was the same
among mice from which samples were first obtained after day
194 (July 13) (9 of 10), a time representing peak host-seeking
activity by I. scapularis nymphs [34], as among those from
which samples were first obtained on or before that date (25
of 32) ( ). Accordingly, we estimated a weighted averageP 1 .1
of the incidence rate of seroconversion in P. leucopus mice for
the entire trapping season. In total, 18 of 26 mice seroconverted
within 3 weeks, and 16 of 21 mice seroconverted within 4 weeks.
The weighted average incidence rate over the 3- and 4-week
periods was 0.2 cases/mouse/week, or 29 infections/1000
mouse-days. From the combined data in figure 4, we estimated
that 50% of uninfected P. leucopus mice became infected with
B. burgdorferi within 23 days. For samples obtained logitudi-
nally in 1998, seroconversion in whole-cell EIA was associated
with a higher prevalence of antibodies to OspC detectable by
immunoblot: 14 (82%) of 17 mice that seroconverted had an-
tibodies to OspC in the second sample.
Detection of B. burgdorferi DNA in mice blood. Infection
of P. leucopus was further investigated by a PCR assay for the
p66 gene in a random selection of 187 blood samples from 152
mice obtained during different collection periods during both
years. Eight (11.3%) of 71 blood samples from 1998 and 11
(9.5%) of 116 samples from 1999 ( ) were found to beP 1 .1
positive for B. burgdorferi DNA (figure 3). The frequencies of
PCR-positive samples were similar during different trapping
periods: 10 (13.2%) of 76 samples from days 146–181, 2 (3.4%)
of 58 samples from days 182–212, and 7 (13.2%) of 53 samples
from days 215–239 ( ). Among paired samples from 32P 1 .1
individual mice, 3 (10%) were found to be positive on 1 oc-
casion but not on the other: samples from 2 mice at the first
testing and from 1 mouse at the second testing.
The mean OD value, by whole-cell EIA, for the PCR-positive
and -negative samples was 0.16 (0.10–0.22) and 0.23 (0.20–
0.25), respectively, in 1998 ( ), and 0.82 (0.64–1.00) andP 1 .05
0.77 (0.68–0.86), respectively, in 1999 ( ). In contrast,P 1 .1
when immunoblot analysis was performed on the same blood
sample, antibody to OspC was detected in 42 (70%) of 60 PCR-
negative samples but in only 2 (29%) of 7 PCR-positive samples
( , Fisher’s exact test).P ! .05
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DISCUSSION
Our study has elaborated on the findings of previous investi-
gations of B. burgdorferi infection of P. leucopus mice in the
field and in the laboratory [6–15] and is the most compre-
hensive to date, in terms of the following: (1) the inclusion of
both laboratory and field P. leucopus mice; (2) the extensiveness
of the trapping of P. leucopus mice in a single, well-characterized
locale; (3) the continuation of the study over the course of 2
transmission seasons; and (4) the use of PCR for direct path-
ogen detection, as well as serologic testing to estimate incidence
and prevalence of infection. On the basis of our review of the
literature, the present study of enzootic infection in a reservoir
population appears to be the most comprehensive to date, for
any vectorborne zoonosis.
Our estimates of the population sizes of P. leucopus mice and
their fluctuations at the experimental sites were within the range
found by investigators in other studies of the northeastern
United States [35–38]. Although population sizes varied be-
tween the 2 years, the number of the studied field mice was
highly representative and included nearly 80% of the popula-
tions from both years.
For the samples obtained in 1998, the whole-cell EIA was
based on B. burgdorferi B31 cells producing comparatively high
amounts of OspA and low amounts of OspC [39], a protein
profile similar to those of most commercial and reference EIA
kits [33]. For the samples obtained in 1999, we used B314 cells
of the same genetic background, but they produced no OspA
and abundant OspC [24], which presumably improved the as-
say’s performance by yielding wider range of values above the
cutoff, without a loss of specificity. Among the several antigens
that were examined, OspC was most frequently bound by an-
tibodies in the samples from the mice, as found elsewhere [6].
Longitudinal sampling allowed us to relate the dynamics of
the B. burgdorferi infection to the established pattern of activity
of I. scapularis ticks during transmission season. Because
nymphs become active in May [34, 40], the samples found to
be seropositive at the outset of the study period are attributable,
in part, to early infections, presumably beginning in mid-April
or early May. Maternal transfer of antibodies, as suggested by
Mather et al. [41], and overwintering by adult mice are 2 pos-
sible contributors to seropositivity in the spring. However, our
finding that juvenile and subadult mice had significantly lower
antibody levels than did adult mice indicates that transplacental
antibodies account for only a minority of the seropositive mice
in the spring. Overwintering is also not likely a major factor
in early seropositivity; only ∼2% of mice overwinter (J.T., un-
published data).
Both the prevalence of seropositive mice and the mean levels
of anti–B. burgdorferi antibody in the population increased over
the course of trapping in both years. This increase could partly
be explained by a collective increase in antibody titers in in-
dividual mice as their immune responses to the organism de-
velop. In addition, the steady incidence rate of 0.2 cases/mouse/
week and the PCR-positivity rate of ∼10% over both years’
trapping periods indicate that the risk of infection remains the
same during the spring and summer, as suggested elsewhere
[12]. One possible explanation for a constant risk of infection
of mice while numbers of host-seeking I. scapularis nymphs
fluctuate is the combination of abundant infected nymphs and
the high efficiency of transmission of the spirochete by nymphs
to mice [7].
The incidence rate from the seroconversion data was 3 times
higher than the rate estimated by Hofmeister et al. for a natural
population of P. leucopus mice in Maryland [6]. Maryland gen-
erally has lower endemicity of LB than does Connecticut [2],
but, even so, these investigators may have underestimated the
incidence, because they used in vitro cultivation of the spiro-
chete. Our PCR assay of the blood samples indicated a prev-
alence of bacteremia of ∼10%, but this estimate also probably
underestimated the prevalence of infected mice that could
transmit B. burgdorferi to feeding larvae. Given the transient
presence and low numbers of spirochetes in the blood [12, 42],
seroconversion may be preferable to culture as an indicator of
first-time infections with B. burgdorferi.
One drawback, however, of using seroconversion figures to
estimate incidence is that reinfections would be difficult to
detect without a strain-specific B. burgdorferi immunoassay.
The whole-cell and immunoblot assays used in the present
study were not strain specific [43]. The finding that a majority
of mice were seropositive at or soon after the outset of obtaining
samples, with the prevalence of PCR positivity more-or-less
constant throughout the study, indicates that second, third, and
even fourth infections occur in individual mice during the
transmission period. Anti–B. burgdorferi antibodies may take
2–3 weeks to appear in the blood after infection, but, thereafter,
antibodies are present in the blood of mice for several months
[14]. Bacteremia with B. burgdorferi, on the other hand, lasts
no longer than a few weeks [44, 45]. The great majority of
PCR-positive mice in the present study were also found to be
seropositive, an indication that the antibodies to the spirochete
predated the current infection. If the antibodies were already
present, then they had either decreased below a level sufficient
for prevention or were ineffective against the newly infecting
strain [46].
One of the determinants of strain-specific immunity to B.
burgdorferi appears to be antibody to OspC [47]. The frequent
occurrence of antibodies to OspC among the mice, detectable
by immunoblot, indicates that this protein is expressed by B.
burgdorferi during infection of P. leucopus mice. The finding
that PCR-positive mice were less likely to have anti-OspC an-
tibodies detectable by immunoblot than were PCR-negative
D
ow
nloaded from
 https://academ
ic.oup.com
/jid/article-abstract/189/8/1515/821767 by guest on 23 August 2019
1522 • JID 2004:189 (15 April) • Bunikis et al.
mice supports the proposal that immunity to OspC may pro-
vide positive selection of ospC genes in this area [48, 49].
There was no apparent illness among the mice, whether se-
ropositive or not, which is an observation that is consistent
with the report of Hofmeister et al. [6]. Mild or no disease is
a characteristic of infection in enzootic reservoirs [50], but the
high incidence of infection with B. burgdorferi is unusual in
comparison with other human zoonotic diseases with enzootic
transmission cycles [51, 52]. Nearly all the P. leucopus mice in
the study area became infected during the transmission season,
a finding more typical of a epizootic outbreak (e.g., of plague
or Sin Nombre virus) [53–55].
High prevalence of antibodies to B. burgdorferi appears to
have no effect on the reservoir competence of P. leucopus mice
for passing the spirochete to naive I. scapularis larvae later in
the same transmission season. Monitoring the prevalence of B.
burgdorferi infection of I. scapularis nymphs in the study area
for several consecutive years revealed no major fluctuations
(J.T., unpublished data). This is in contrast to the reduction of
the reservoir competence of P. leucopus mice for Anaplasma
phagocytophilum after experimentally induced immunity to this
other pathogen, which is transmitted by I. scapularis ticks in
the same area [56].
Although the sizes of the mouse populations differed dur-
ing the 2 seasons, the levels and monthly patterns of sero-
prevalence and PCR positivity in mice were similar for both
years. These findings, together with the short duration of
bacteremia and the infrequent survival of P. leucopus mice
through the winter at the field site are further evidence that
overwintering ticks are critical for maintenance of B. burg-
dorferi in the area. This is in contrast to hantavirus enzootic
infection, which has a prevalence that is inversely related to
the size of the population of the reservoir Peromyscus mice,
and long-lived, persistently infected rodents are thought to
maintain the virus over winter [57].
In conclusion, almost all P. leucopus mice became infected
with B. burgdorferi during a single transmission season at a
study site in Connecticut that is representative of the landscape
of much of the northeastern United States. The findings in-
dicate that reinfection of mice is common and that the presence
of antibodies to the organism does not prevent bacteremia,
which probably occurs with a different strain of B. burgdorferi.
The finding of a high prevalence of antibodies to OspC among
the P. leucopus mice in the population studied is consistent with
the proposal that OspC is an important determinant of strain-
specific immunity [47]. On the other hand, although P. leucopus
mice in the laboratory could produce an immune response to
injected OspA in this or another study [19], naturally infected
mice rarely had antibodies to this antigen, a finding that con-
firms the reports of Hofmeister et al. [6] and Brunet et al. [13].
This supports the application of OspA (or another appropriate
antigen) as a transmission-blocking vaccine directed at P. leu-
copus mice and other reservoirs of B. burgdorferi [17, 19].
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